Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Intrinsic Value
Northeast Pharmaceutical Group Co., Ltd. engages in the manufacturing and sales of pharmaceutical products. [ Read More ]
The intrinsic value of one Northeast Pharmaceutical Group Co Ltd stock under the Base Case scenario is 6.46 CNY. Compared to the current market price of 4.77 CNY, Northeast Pharmaceutical Group Co Ltd is Undervalued by 26%.
Valuation Backtest
Northeast Pharmaceutical Group Co Ltd
Run backtest to discover the historical profit from buying and selling Northeast Pharmaceutical Group Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Northeast Pharmaceutical Group Co Ltd
Current Assets | 8.3B |
Cash & Short-Term Investments | 2B |
Receivables | 3B |
Other Current Assets | 3.3B |
Non-Current Assets | 5.7B |
PP&E | 4.7B |
Intangibles | 861.3m |
Other Non-Current Assets | 118.4m |
Current Liabilities | 8.6B |
Accounts Payable | 1.8B |
Accrued Liabilities | 47.8m |
Short-Term Debt | 5.1B |
Other Current Liabilities | 1.7B |
Non-Current Liabilities | 727.6m |
Long-Term Debt | 170.9m |
Other Non-Current Liabilities | 556.7m |
Earnings Waterfall
Northeast Pharmaceutical Group Co Ltd
Revenue
|
8.6B
CNY
|
Cost of Revenue
|
-5.2B
CNY
|
Gross Profit
|
3.4B
CNY
|
Operating Expenses
|
-3.1B
CNY
|
Operating Income
|
318.2m
CNY
|
Other Expenses
|
123.6m
CNY
|
Net Income
|
441.8m
CNY
|
Free Cash Flow Analysis
Northeast Pharmaceutical Group Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Northeast Pharmaceutical Group Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Northeast Pharmaceutical Group Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Northeast Pharmaceutical Group Co Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Northeast Pharmaceutical Group Co Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Northeast Pharmaceutical Group Co Ltd
Shareholder Return
Price
Northeast Pharmaceutical Group Co Ltd
Average Annual Return | 5.32% |
Standard Deviation of Annual Returns | 21.36% |
Max Drawdown | -86% |
Market Capitalization | 6.8B CNY |
Shares Outstanding | 1 445 538 524 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Northeast Pharmaceutical Group Co., Ltd. engages in the manufacturing and sales of pharmaceutical products. The company is headquartered in Shenyang, Liaoning and currently employs 7,102 full-time employees. The firm's main products include bulk pharmaceutical chemicals (BPCs), formulations and bio-diagnostic reagents. The firm is also involved in the pharmaceutical engineering business through its subsidiaries. The firm mainly conducts its business in domestic market and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Northeast Pharmaceutical Group Co Ltd stock under the Base Case scenario is 6.46 CNY.
Compared to the current market price of 4.77 CNY, Northeast Pharmaceutical Group Co Ltd is Undervalued by 26%.